Trial Profile
A Study to Evaluate the Correlation between Single Nucleotide Polymorphisms in Adsorption, Distribution, Metabolism, and Excretion (ADME) Genes and Skin Rash in Advanced NSCLC Patients Treated With Erlotinib
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Jun 2016
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic
- 20 Jun 2016 New trial record